Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Kibio Inc
Profile last edited on: 11/17/23      CAGE: 8DG76      UEI: G5JDYJ4F55P5

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2019
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

3112 Albany Circle
Davis, CA 95618
   (916) 734-4417
   N/A
   N/A
Location: Single
Congr. District: 04
County: Yolo

Public Profile

KiBio has developed new small molecule inhibitors of galectin-1 for malignant peripheral nerve sheath tumor (MPNST) and prostate cancer. Having undertaken what would appear to be a very interesting - and potentially important project - unfortunately it has proved almost impossible to garner any useful information about the firm and its principals. Any assistance from the principals - and/or those who know them - would be appreciated

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$400,000
Phase II Dollars
$0
Total Awarded
$400,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NIH $400,000
Project Title: Novel small-molecule therapeutics for malignant peripheral nerve sheath tumor

Key People / Management

  Tsung-Chieh Shih -- Chief Executive Office

  Hsiao-Chi Wang

Company News

There are no news available.